Altimmune Inc (GB:0A4C)

Altimmune (0A4C) Cash flow


Altimmune Cash Flow

GB:0A4C's free cash flow for Q2 2023 was $-19.38M. For the 2023 fiscal year, GB:0A4C's free cash flow was decreased by $27.84M and operating cash flow was $-19.38M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -71.15M$ -62.59M$ -78.24M$ -34.31M$ -9.60M$ -9.39M
Investing Cash Flow
$ -7.13M$ -73.40M$ 87.52M$ -72.23M$ -28.29M$ -1.00M
Financing Cash Flow
$ 44.78M$ 56.78M$ 65.10M$ 213.49M$ 12.53M$ 32.49M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 747.98M$ 111.13M$ 190.33M$ 115.95M$ 9.00M$ 34.35M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
--$ 0.00$ 1.79K$ 0.00$ 57.21K
Issuance Of Capital Stock
$ 45.38M$ 56.35M$ 65.04M$ 172.32M$ 12.67M$ 37.40M
Issuance Of Debt
--$ 0.00$ 632.00K$ 0.00$ 0.00
Repayment Of Debt
--$ 0.00$ -632.00K$ -292.00K$ -1.55M
Free Cash Flow
$ -71.29M$ -62.71M$ -90.55M$ -34.65M$ -9.63M$ -10.40M
Domestic Sales
Foreign Sales
Currency in USD

Altimmune Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis